glp-1 obesity drug news today september 29 2025 More people with type 1 diabetes are using drugs, study finds, despite limited evidence on safety or effectiveness How to Invest in GLP-1

Glucagon-like peptide-1 agonist drugs have been surging in popularity, and manufacturers are scurrying to keep up with demand

Dual- and multi-receptor agonists may be a novel drug class to treat obesity and type 2 diabetes mellitus with high efficacy.

GLP-1 medications like Ozempic and Mounjaro may support fertility by aiding weight loss, reducing inflammation, and improving hormone balance, but theyre not a cure for infertility

Weight-suppressant drugs have helped millions to lose weight

I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance)